81432 Hrdtry brst ca-rlatd do 5+
Also known as: hereditary breast cancer panel, BRCA panel, breast cancer susceptibility testing
Genetic testing for hereditary breast cancer-related disorders including 5 or more genes.
In Plain Language
cancer risk gene test; breast cancer family screening
Clinical Context
Identifies mutations in BRCA1, BRCA2, and other cancer-related genes; essential for cancer risk stratification in families with breast or ovarian cancer.
RVU Information
CPT 81432 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81432?
CPT 81432 (Hrdtry brst ca-rlatd do 5+) is a Pathology & Lab code. Genetic testing for hereditary breast cancer-related disorders including 5 or more genes.
Who uses CPT code 81432?
CPT 81432 is used by oncology, genetics, gynecology. Identifies mutations in BRCA1, BRCA2, and other cancer-related genes; essential for cancer risk stratification in families with breast or ovarian cancer.
When is CPT 81432 used?
Identifies mutations in BRCA1, BRCA2, and other cancer-related genes; essential for cancer risk stratification in families with breast or ovarian cancer.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.